ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,165Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 617

$609K Total Retail Price of All Prescriptions

Rank: 48 out of 617

528 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 528 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 528 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 12,243 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 703 661 1 2
LEVOTHYROXINE SODIUM 438 406 2 1
FUROSEMIDE 342 338 3 4
OMEPRAZOLE 339 323 4 3
WARFARIN SODIUM 335 299 5 7
AMLODIPINE BESYLATE 307 283 6 6
MELOXICAM 284 276 7 24
LISINOPRIL 270 257 8 5
METFORMIN HCL 254 234 9 9
LOSARTAN POTASSIUM 230 221 10 22
LOSARTAN-HYDROCHLOROTHIAZIDE 208 191 11 46
POTASSIUM CHLORIDE 204 193 12 10
HYDROCHLOROTHIAZIDE 204 194 12 13
HYDROCODONE-ACETAMINOPHEN 202 178 S3 14 8
CARVEDILOL 202 191 14 19
TRAMADOL HCL 188 179 16 15
ATORVASTATIN CALCIUM 184 174 17 14
ENALAPRIL MALEATE 171 171 18 34
CRESTOR 169 169 19 28
SERTRALINE HCL 165 154 20 20
GLIMEPIRIDE 164 152 21 33
ALLOPURINOL 162 150 22 27
NEXIUM 130 127 23 43
BISOPROLOL FUMARATE 126 113 24 100
ALENDRONATE SODIUM 123 123 25 25
METOPROLOL SUCCINATE 122 122 26 12
AMLODIPINE BESYLATE-BENAZEPRIL 116 104 27 80
ATENOLOL 110 103 28 17
GABAPENTIN 109 96 29 16
METOPROLOL TARTRATE 109 108 29 11
ZOLPIDEM TARTRATE 107 72 31 23
DIGOXIN 103 103 32 48
DONEPEZIL HCL 103 103 32 30
ADVAIR DISKUS 102 86 34 38
NAMENDA 99 99 35 35
TAMSULOSIN HCL 98 98 36 26
FAMOTIDINE 98 82 36 54
PANTOPRAZOLE SODIUM 92 83 38 37
BYSTOLIC 88 88 39 64
POLYETHYLENE GLYCOL 3350 86 84 40 32
SPIRIVA 83 55 41 61
ACTOS 79 76 42 85
LANTUS 77 66 43 39
RANITIDINE HCL 77 77 43 40
METFORMIN HCL ER 76 61 45 72
CEPHALEXIN 74 70 46 68
PREDNISONE 73 69 47 31
PRAVASTATIN SODIUM 72 72 48 21
FLUTICASONE PROPIONATE 72 69 48 36
VENLAFAXINE HCL ER 71 57 50 76
DIOVAN 70 69 51 41
FENTANYL 65 63 S2 52 45
AVODART 64 64 53 144
BENAZEPRIL HCL 62 61 54 44
NAPROXEN 62 57 54 101
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 61 56 29
DILTIAZEM ER 59 58 57 81
FENOFIBRATE 59 59 57 58
CELEBREX 56 56 59 63
PLAVIX 55 50 60 86
BISOPROLOL-HYDROCHLOROTHIAZIDE 54 54 61 87
LANTUS SOLOSTAR 53 53 62 115
CYCLOBENZAPRINE HCL 52 38 R 63 74
SYNTHROID 52 52 63 59
CHLORTHALIDONE 52 29 63 123
CLOPIDOGREL 52 52 63 53
ROPINIROLE HCL 51 40 67 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.